RetiSpec is an artificial intelligence (AI) medical imaging company developing tools for the early detection of disease biomarkers in the eye.
Our goal is to enable widespread early detection of Alzheimer’s disease with accessible and scalable screening.
ADAM GRIBBLE, PHD
In The News
Toronto, ON, Canada
© 2021 RetiSpec Inc. All rights reserved.
RetiSpec's technology is currently for research use only